A placebo-controlled trial of topical 8% arildone cream early in recurrent genital herpes.

Arildone is an aryl diketone which is inhibitory in vitro against herpes simplex virus type 2 at a concentration of 2 micrograms/ml or less. One hundred forty-five patients with recurrent genital herpes were enrolled in a multicenter, randomized, placebo-controlled, double-blind trial to evaluate th...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
I whakaputaina i:	Antimicrob Agents Chemother
Ngā kaituhi matua:	Douglas, J M, Judson, F N, Levin, M J, Bosso, J A, Spruance, S L, Johnston, J M, Corey, L, McMillan, J A, Weiner, L B, Frank, J A
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	American Society for Microbiology (ASM) 1986
Ngā marau:	Research Article
Urunga tuihono:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180415/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3521487/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.3.464
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

A placebo-controlled trial of topical 8% arildone cream early in recurrent genital herpes.

Ngā tūemi rite